130 related articles for article (PubMed ID: 16319095)
21. Peripheral arterial disease in patients with Behçet's disease.
Balta I; Balta S; Demirkol S; Ekiz O
Rheumatol Int; 2014 Apr; 34(4):589-90. PubMed ID: 23535820
[No Abstract] [Full Text] [Related]
22. Treatment for diplopia in patients with myasthenia gravis.
Park KA; Oh SY
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):895-901. PubMed ID: 23275035
[TBL] [Abstract][Full Text] [Related]
23. Cognitive testing in Fabry disease: pilot using a brief computerized assessment tool.
Elstein D; Doniger GM; Altarescu G
Isr Med Assoc J; 2012 Oct; 14(10):624-8. PubMed ID: 23193784
[TBL] [Abstract][Full Text] [Related]
24. Miller Fisher syndrome mimicking ocular myasthenia gravis.
Anthony SA; Thurtell MJ; Leigh RJ
Optom Vis Sci; 2012 Dec; 89(12):e118-23. PubMed ID: 23190719
[TBL] [Abstract][Full Text] [Related]
25. Lifestyle risk factors for ischemic stroke and transient ischemic attack in young adults in the Stroke in Young Fabry Patients study.
von Sarnowski B; Putaala J; Grittner U; Gaertner B; Schminke U; Curtze S; Huber R; Tanislav C; Lichy C; Demarin V; Basic-Kes V; Ringelstein EB; Neumann-Haefelin T; Enzinger C; Fazekas F; Rothwell PM; Dichgans M; Jungehulsing GJ; Heuschmann PU; Kaps M; Norrving B; Rolfs A; Kessler C; Tatlisumak T;
Stroke; 2013 Jan; 44(1):119-25. PubMed ID: 23150649
[TBL] [Abstract][Full Text] [Related]
26. The ocular surface in the Behçet's disease patient.
Gunduz A; Cumurcu T; Demirel EE; Akpolat N; Karıncaoglu Y
Can J Ophthalmol; 2012 Oct; 47(5):429-34. PubMed ID: 23036544
[TBL] [Abstract][Full Text] [Related]
27. Differential diagnosis and management of Behçet syndrome.
Ambrose NL; Haskard DO
Nat Rev Rheumatol; 2013 Feb; 9(2):79-89. PubMed ID: 23007742
[TBL] [Abstract][Full Text] [Related]
28. Does Behcet's disease associate with neuropathic pain syndrome and impaired well-being?
Evcik D; Dogan SK; Ay S; Cuzdan N; Guven M; Gurler A; Boyvat A
Clin Rheumatol; 2013 Jan; 32(1):33-6. PubMed ID: 23001467
[TBL] [Abstract][Full Text] [Related]
29. The many faces of Behçet's disease.
Chick JF; Miller JD; Bair RJ; Madan R
J Cardiovasc Med (Hagerstown); 2013 Nov; 14(11):833-5. PubMed ID: 22964649
[TBL] [Abstract][Full Text] [Related]
30. Clinical course of intestinal Behcet's disease during the first five years.
Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
Dig Dis Sci; 2013 Feb; 58(2):496-503. PubMed ID: 22899244
[TBL] [Abstract][Full Text] [Related]
31. Learning from HSV-infected mice as a model of Behçet's disease.
Sohn S; Lee ES; Bang D
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S96-103. PubMed ID: 22766172
[TBL] [Abstract][Full Text] [Related]
32. Pseudoacromegalic facial features in Fabry disease.
Hogarth V; Hughes D; Orteu CH
Clin Exp Dermatol; 2013 Mar; 38(2):137-9. PubMed ID: 22731890
[TBL] [Abstract][Full Text] [Related]
33. Behcet's disease: is there a gender influence on clinical manifestations?
Davatchi F; Shahram F; Chams-Davatchi C; Sadeghi Abdollahi B; Shams H; Nadji A; Faezi T; Akhlaghi M; Ghodsi Z; Larimi R; Ashofteh F
Int J Rheum Dis; 2012 Jun; 15(3):306-14. PubMed ID: 22709493
[TBL] [Abstract][Full Text] [Related]
34. Major vessel thrombosis in Behçet's disease: the dilemma of anticoagulant therapy - the approach of rheumatologists from different countries.
Tayer-Shifman OE; Seyahi E; Nowatzky J; Ben-Chetrit E
Clin Exp Rheumatol; 2012; 30(5):735-40. PubMed ID: 22703971
[TBL] [Abstract][Full Text] [Related]
35. Ice pack test: is it obsolete?
Rajasekharan C; Anishkumar V; Suresh MK
BMJ Case Rep; 2011 Jul; 2011():. PubMed ID: 22689834
[TBL] [Abstract][Full Text] [Related]
36. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
Wang X; Zhang MF; Xie J; Li ZL; Wang P
Anat Rec (Hoboken); 2012 Jul; 295(7):1168-73. PubMed ID: 22641412
[TBL] [Abstract][Full Text] [Related]
37. Canakinumab in a patient with juvenile Behcet's syndrome with refractory eye disease.
Ugurlu S; Ucar D; Seyahi E; Hatemi G; Yurdakul S
Ann Rheum Dis; 2012 Sep; 71(9):1589-91. PubMed ID: 22586166
[No Abstract] [Full Text] [Related]
38. Long-term clinical outcomes of Crohn's disease and intestinal Behcet's disease.
Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
Inflamm Bowel Dis; 2013 Jan; 19(1):99-105. PubMed ID: 22508364
[TBL] [Abstract][Full Text] [Related]
39. Is there a need for audiologic evaluation in patients with Behçet disease?
Cinar S; Cinar F; Kiran S
Ear Nose Throat J; 2012 Mar; 91(3):E15-9. PubMed ID: 22430342
[TBL] [Abstract][Full Text] [Related]
40. Low-dose glucocorticoid therapy complements the pituitary-adrenocortical system and reduces anxiety and insomnia in myasthenia gravis patients.
Ito S; Masuda M; Tanaka S; Takagi M; Tanaka C; Yamada N; Nakajima K; Akashi T; Hirano T; Utsumi H
Clin Neuropharmacol; 2012; 35(1):30-6. PubMed ID: 22240858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
